Latest
DataBank and Goodman Group Launch 32MW Los Angeles Data Center to Address Capacity CrunchDataBank and Goodman Group Launch 32MW Los Angeles Data Center to Address Capacity Crunch|Gecko RoboticsGecko Robotics|LaunchDarklyLaunchDarkly|Sedron Technologies Secures Up to $500M to Scale Waste-to-Resource and Water Recycling InfrastructureSedron Technologies Secures Up to $500M to Scale Waste-to-Resource and Water Recycling Infrastructure|Paige Raises $2.5M to Simplify Digital Estate Planning and Wealth Transfer for Families and BanksPaige Raises $2.5M to Simplify Digital Estate Planning and Wealth Transfer for Families and Banks|AfterQuery Raises $30M Series A to Build High-Quality Training Data for AI Using Expert NetworksAfterQuery Raises $30M Series A to Build High-Quality Training Data for AI Using Expert Networks|Juno Raises $12M Seed to Automate Tax Preparation and Accounting Workflows for CPA FirmsJuno Raises $12M Seed to Automate Tax Preparation and Accounting Workflows for CPA Firms|Luminai Raises $38M Series B to Automate Healthcare Operations With AI and Reduce Administrative CostsLuminai Raises $38M Series B to Automate Healthcare Operations With AI and Reduce Administrative Costs|SiMa.ai Secures Strategic Investment From Micron to Power Edge AI and Embedded Machine Learning SystemsSiMa.ai Secures Strategic Investment From Micron to Power Edge AI and Embedded Machine Learning Systems|SiFive Raises $400M at $3.65B Valuation to Scale RISC-V Chips for Data Centers and AI WorkloadsSiFive Raises $400M at $3.65B Valuation to Scale RISC-V Chips for Data Centers and AI Workloads|DataBank and Goodman Group Launch 32MW Los Angeles Data Center to Address Capacity CrunchDataBank and Goodman Group Launch 32MW Los Angeles Data Center to Address Capacity Crunch|Gecko RoboticsGecko Robotics|LaunchDarklyLaunchDarkly|Sedron Technologies Secures Up to $500M to Scale Waste-to-Resource and Water Recycling InfrastructureSedron Technologies Secures Up to $500M to Scale Waste-to-Resource and Water Recycling Infrastructure|Paige Raises $2.5M to Simplify Digital Estate Planning and Wealth Transfer for Families and BanksPaige Raises $2.5M to Simplify Digital Estate Planning and Wealth Transfer for Families and Banks|AfterQuery Raises $30M Series A to Build High-Quality Training Data for AI Using Expert NetworksAfterQuery Raises $30M Series A to Build High-Quality Training Data for AI Using Expert Networks|Juno Raises $12M Seed to Automate Tax Preparation and Accounting Workflows for CPA FirmsJuno Raises $12M Seed to Automate Tax Preparation and Accounting Workflows for CPA Firms|Luminai Raises $38M Series B to Automate Healthcare Operations With AI and Reduce Administrative CostsLuminai Raises $38M Series B to Automate Healthcare Operations With AI and Reduce Administrative Costs|SiMa.ai Secures Strategic Investment From Micron to Power Edge AI and Embedded Machine Learning SystemsSiMa.ai Secures Strategic Investment From Micron to Power Edge AI and Embedded Machine Learning Systems|SiFive Raises $400M at $3.65B Valuation to Scale RISC-V Chips for Data Centers and AI WorkloadsSiFive Raises $400M at $3.65B Valuation to Scale RISC-V Chips for Data Centers and AI Workloads
Back to articles
•Jesse Landry

Earendil Labs Raises $787M to Expand AI-Driven Biologics Platform

Funding Details

Amount

$787M

Every so often, a funding round reveals more than capital, it reveals alignment. Earendil Labs just pulled in $787M, with Dimension Capital stepping up alongside DST Global and Hillhouse Investment, and a bench that reads like a biotech and capital markets all-star roster. Sanofi in the mix. Biotech Development Fund backed by Hillhouse and Pfizer. INCE Capital, Luminous Ventures, Miracle Capital. This isn’t a round you celebrate with a press release and a pat on the back. This is the kind you study twice.

Jian Peng and Zhenping Zhu didn’t build a science project. They built a system that treats biology like code and protein design like a language model with consequences. Antibodies, bispecifics, full-stack biologics discovery powered by deep learning and high-throughput validation. Not theory. Production. Over 40 programs moving through the pipeline, with HXN-1001 already stepping into Phase 2 territory. That’s not potential. That’s velocity with direction.

And let’s be honest, biotech has flirted with AI for years. Plenty of slide decks. Plenty of “platform” talk. Earendil Labs is what happens when AI stops being the assistant and starts being the engine. Design, test, learn, repeat. Faster loops. Better molecules. Less guesswork dressed up as genius.

The capital here isn’t just fuel. It’s alignment. You don’t get this mix of investors unless the story holds up under real scrutiny. Global funds, strategic pharma, cross-border firepower between the U.S. and China. That’s not accidental. That’s architecture.

The Sanofi collaboration alone tells you where this is headed. Autoimmune and inflammatory diseases, bispecific antibodies, global development and commercialization baked in. Pair that with WuXi XDC on the ADC side and now you’re not just discovering drugs, you’re wiring them straight into the machinery that gets them to patients.

There’s a lesson sitting under all this if you’re paying attention. The market isn’t rewarding noise. It’s rewarding systems that compound. Earendil Labs didn’t chase headlines. They built leverage. AI that actually ships molecules. Partnerships that actually move programs. Capital that actually accelerates.

Related Articles

More from Jesse Landry

Trending

View all posts